Profund Advisors LLC Has $251,000 Stock Position in Maximus, Inc. (NYSE:MMS)

Profund Advisors LLC lowered its stake in Maximus, Inc. (NYSE:MMS) by 18.1% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,928 shares of the health services provider’s stock after selling 646 shares during the period. Profund Advisors LLC’s holdings in Maximus were worth $251,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. Rise Advisors LLC boosted its position in Maximus by 1,445.0% in the first quarter. Rise Advisors LLC now owns 309 shares of the health services provider’s stock valued at $26,000 after buying an additional 289 shares in the last quarter. GAMMA Investing LLC lifted its holdings in shares of Maximus by 224.5% during the second quarter. GAMMA Investing LLC now owns 344 shares of the health services provider’s stock worth $29,000 after purchasing an additional 238 shares during the period. Blue Trust Inc. lifted its holdings in shares of Maximus by 201.5% during the second quarter. Blue Trust Inc. now owns 392 shares of the health services provider’s stock worth $33,000 after purchasing an additional 262 shares during the period. Kapitalo Investimentos Ltda acquired a new position in shares of Maximus during the fourth quarter worth $52,000. Finally, Archer Investment Corp lifted its holdings in shares of Maximus by 8,788.9% during the second quarter. Archer Investment Corp now owns 800 shares of the health services provider’s stock worth $69,000 after purchasing an additional 791 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Price Performance

Shares of NYSE:MMS opened at $92.70 on Friday. The firm has a market cap of $5.64 billion, a PE ratio of 24.33 and a beta of 0.76. The firm’s fifty day moving average is $89.92 and its 200-day moving average is $86.38. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.59 and a current ratio of 1.59. Maximus, Inc. has a 52 week low of $72.39 and a 52 week high of $93.97.

Maximus (NYSE:MMS) last issued its quarterly earnings results on Wednesday, August 7th. The health services provider reported $1.74 EPS for the quarter, topping analysts’ consensus estimates of $1.47 by $0.27. The company had revenue of $1.31 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a net margin of 5.59% and a return on equity of 20.91%. Maximus’s revenue was up 10.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.78 earnings per share. Sell-side analysts predict that Maximus, Inc. will post 6.12 earnings per share for the current year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Saturday, August 31st. Investors of record on Thursday, August 15th were issued a $0.30 dividend. The ex-dividend date was Thursday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.29%. Maximus’s payout ratio is 31.50%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.